Metraipolis › archive › dc_e034c9b86242

Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation — Europe PMC PMID:42802858

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42802858
DOI
10.1002/mco2.71030
License (as archived)
solo-consultazione
Archived
2026-10-07T20:45:50.099Z
SHA-256 of the archived text
08e0c724359b076382833d3c83867ac332a97b51433a054c434e89fc3b02a9cc
Stable URL of this page
https://metraipolis.com/documento/dc_e034c9b86242

How to cite

Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation — Europe PMC PMID:42802858 — Europe PMC (en), https://europepmc.org/article/MED/42802858 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e034c9b86242 (Metraipolis archive dc_e034c9b86242, sha256 08e0c724359b076382833d3c83867ac332a97b51433a054c434e89fc3b02a9cc)
BibTeX
@misc{dce034c9b86242,
  title = {Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation — Europe PMC PMID:42802858},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42802858},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e034c9b86242; sha256 08e0c724359b076382833d3c83867ac332a97b51433a054c434e89fc3b02a9cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42802858. Agents can read the archived copy with the MCP tool read_document.